Mathias Kahl | Head of Development
IDT Biologika GmbH

Mathias Kahl is currently serving as the Head of Development at IDT Biologika GmbH. With over 15 years of experience in the pharmaceutical and biotechnology industry, Mathias has a proven track record of leading successful research and development projects in the global vaccine industry.

Throughout his career, Mathias has demonstrated a strong commitment to driving innovation and strategic partnerships to advance vaccine technologies. His expertise lies in overseeing the entire development process, from initial research and preclinical studies to clinical trials and regulatory approval. 

Mathias has a deep understanding of the scientific principles behind vaccine development. He is passionate about leveraging cutting-edge technologies and novel approaches to address global health challenges through the development of safe and effective vaccines.

As a speaker at the World Vaccine Congress Europe 2026, Mathias will share his insights on the latest trends in research, development, and strategic partnering in the vaccine industry. Attendees can expect to gain valuable knowledge from Mathias's expertise and experience, making his session a must-attend for professionals looking to stay at the forefront of vaccine innovation.